Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Optimal management for people with severe spasticity

Authors Shilt J, Seibert, Kadyan

Received 16 February 2012

Accepted for publication 11 April 2012

Published 4 October 2012 Volume 2012:2 Pages 133—140

DOI https://doi.org/10.2147/DNND.S16630

Review by Single-blind

Peer reviewer comments 3


Jeffrey Shilt,1 Pennie S Seibert,2 Vivek Kadyan1

1Idaho Spasticity Program, Saint Alphonsus Health Systems, Boise, ID, 2Department of Psychology, Boise State University, Boise, ID, USA

Abstract: Spasticity is characterized by velocity-dependent increase in tonic stretch reflexes and tendon jerks. Many people affected by spasticity receive late treatment, or no treatment, which greatly reduces the potential to regain full motor control and restore function. There is much to consider before determining treatment for people with spasticity. Treatment of pediatric patients increases the complexity, because of the substantial difference between adult and pediatric spasticity. Proper patient evaluation, utilization of scales and measures, and obtaining patient and caregiver history is vital in determining optimal spasticity treatment. Further, taking into consideration the limitations and desires of individuals serve as a guide to best management. We have grouped contributing factors into the IDAHO Criteria to elucidate a multidisciplinary approach, which considers a person's complete field of experience. This model is applied to goal setting, and recognizes the importance of a spasticity management team, comprising the treatment subject, his/her family, the environment, and a supportive, well-informed medical staff. The criteria take into account the complexity associated with diagnosing and treating spasticity, with the ultimate goal of improved function.

Keywords: spasticity treatment modalities, pediatric spasticity management, optimal management for spasticity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]